RNA-armed EVs or engineered EV-like nanoparticles that contain RNA have been successfully utilized in lymphoma models demonstrating for example that siRNA-particles promoted silencing of c-Myc with subsequent activation of poly (ADP-ribose) polymerase-dependent apoptotic pathways in treated λ820 lymphoma cells (86). Here, MYC is linked to lymphoma.